This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okano, M Articles by Purtilo, D T Search for Related Content PubMed PubMed Citation Articles by Okano, M Articles by Purtilo, D T

 Previous Article  |  Next Article 

Clin Microbiol Rev. 1988 July; 1(3): 300-312

Epstein-Barr virus and human diseases: recent advances in diagnosis.

M Okano, G M Thiele, J R Davis, H L Grierson and D T Purtilo

Department of Pathology, University of Nebraska Medical Center, Omaha 68105-1065.

SUMMARY

Since the discovery of Epstein-Barr virus (EBV) from a cultured Burkitt's lymphoma cell line in 1964, the virus has been associated with Burkitt's lymphoma, nasopharyngeal carcinoma, and infectious mononucleosis. During the recent decade, EBV has been etiologically implicated in a broad spectrum of human diseases. The precise role of this virus in these diseases is not well understood, but clearly, defective immunosurveillance against the virus may permit an uncontrolled proliferation of EBV-infected cells. As a result, a growing number of cases of EBV-associated B-cell proliferative diseases or lymphoma have been noted in patients with primary and acquired immunodeficiencies. These lymphoproliferative diseases and others, such as chronic mononucleosis syndrome, are leading to new areas of investigation which are providing information regarding the pathogenetic mechanisms of EBV-induced diseases. The early accurate diagnosis of EBV infection can be achieved by performing EBV-specific serology, detecting for EBV-determined nuclear antigen in tissues, establishing spontaneous lymphoid cell lines, and using molecular hybridization techniques for demonstrating the presence of viral genome in affected lesions.

---

Clin Microbiol Rev. 1988 July; 1(3): 300-312

This article has been cited by other articles:

• Klutts, J. S., Liao, R. S., Dunne, W. M. Jr., Gronowski, A. M. (2004). Evaluation of a Multiplexed Bead Assay for Assessment of Epstein-Barr Virus Immunologic Status. J. Clin. Microbiol. 42: 4996-5000 [Abstract] [Full Text]  
• Stowe, R. P., Pierson, D. L., Barrett, A. D. T. (2001). Elevated Stress Hormone Levels Relate to Epstein-Barr Virus Reactivation in Astronauts. Psychosom. Med. 63: 891-895 [Abstract] [Full Text]  
• Ferrari, M. G., Rivadeneira, E. D., Jarrett, R., Stevceva, L., Takemoto, S., Markham, P., Franchini, G. (2001). HVMNE, a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits. Blood 98: 2193-2199 [Abstract] [Full Text]  
• Xu, J., Ahmad, A., Jones, J. F., Dolcetti, R., Vaccher, E., Prasad, U., Menezes, J. (2000). Elevated Serum Transforming Growth Factor beta 1 Levels in Epstein-Barr Virus-Associated Diseases and Their Correlation with Virus-Specific Immunoglobulin A (IgA) and IgM. J. Virol. 74: 2443-2446 [Abstract] [Full Text]  
• Prang, N. S., Hornef, M. W., Jager, M., Wagner, H. J., Wolf, H., Schwarzmann, F. M. (1997). Lytic Replication of Epstein-Barr Virus in the Peripheral Blood: Analysis of Viral Gene Expression in B Lymphocytes During Infectious Mononucleosis and in the Normal Carrier State. Blood 89: 1665-1677 [Abstract] [Full Text]  
• Seemayer, T. A., Grierson, H., Pirruccello, S. J., Gross, T. G., Weisenburger, D. D., Davis, J., Spiegel, K., Brichacek, B., Sumegi, J. (1993). X-linked Lymphoproliferative Disease. Arch Pediatr Adolesc Med 147: 1242-1245 [Abstract]  
• Palay, D. A., Litoff, D., Krachmer, J. H. (1993). Stromal Keratitis Associated With Epstein-Barr Virus Infection in a Young Child. Arch Ophthalmol 111: 1323-1324 [Abstract]